F12 is the first lysin-based treatment with the potential to be used multiple times on a single patient, making it ideal to treat particularly persistent drug-resistant and drug-sensitive infections.

The team then synthesized a lysin from a bacteriophage, or virus that attacks bacteria, that infects S. hominis. During in vitro experiments, this lysin was found to target only S. hominis , not ...

Odor-causing bacteria in armpits targeted using bacteriophage-derived lysin. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 04 / 240423113115.htm ...

In addition to the Acinetobacter lysin, Bioharmony’s portfolio includes a proprietary line-up of lysins for the treatment for pneumonia, skin, urinary tract and bloodstream infections caused by ...

An Osaka Metropolitan University-led research team has synthesized a lysin that during in vitro experiments targets bacteria responsible for producing odors in human armpits.